Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is EuroEyes International Eye Clinic Current Ratio?
EuroEyes International Eye ClinicHKSE:01846 +2.04%83 Current Ratio is 2.79 as of Dec. 2025, which is 39% below its 10-year median of 4.60. GuruFocus rates HKSE:01846 with a GF Score™ of 83/100 and a GF Value™ of HK$5.56 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 678 Healthcare Providers & Services companies, EuroEyes International Eye Clinic ranks better than 76.25% on this metric.
EuroEyes International Eye Clinic has a current ratio of 2.79. It generally indicates good short-term financial strength.
The historical rank and industry rank for EuroEyes International Eye Clinic's Current Ratio or its related term are showing as below:
HKSE:01846'
s Current Ratio Range Over the Past 10 Years
Min: 0.63 Med: 4.6 Max: 7.09
Current: 2.79
During the past 10 years, EuroEyes International Eye Clinic's highest Current Ratio was 7.09. The lowest was 0.63. And the median was 4.60.
HKSE:01846's Current Ratio is ranked better than 76.25% of 678
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs HKSE:01846: 2.79
EuroEyes International Eye Clinic (HKSE:01846) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
EuroEyes International Eye Clinic Current Ratio Related Terms
EuroEyes International Eye Clinic Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic Current Ratio Chart
HKSE:01846 vs HCA, THC, DVA: Current Ratio Comparison
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's Current Ratio distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic (HKSE:01846) has a Current Ratio of 2.79 as of Dec. 2025. This is 39% below median its historical median of 4.60. Over the past decade, EuroEyes International Eye Clinic's Current Ratio has ranged from 0.63 to 7.09. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #161 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 23.7%.
Is EuroEyes International Eye Clinic's Current Ratio too high?
EuroEyes International Eye Clinic's current Current Ratio of 2.79 is 39% below median its 10-year median of 4.60. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 7.09. The Healthcare Providers & Services industry median Current Ratio is 1.47. EuroEyes International Eye Clinic's value of 2.79 is 89.8% above this industry median. Based on the distribution chart, EuroEyes International Eye Clinic ranks #161 out of 678 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, EuroEyes International Eye Clinic has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #161 out of 678 companies for Current Ratio. This places EuroEyes International Eye Clinic in the top 24% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. EuroEyes International Eye Clinic's value of 2.79 is 89.8% above this benchmark. Historically, EuroEyes International Eye Clinic's own Current Ratio has ranged from 0.63 to 7.09 over the past decade. While the company's 10-year median is 4.60 vs. the industry median of 1.47, EuroEyes International Eye Clinic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EuroEyes International Eye Clinic's current Current Ratio of 2.79 is 89.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current Current Ratio is 2.79, which is 39% below median its own 10-year median of 4.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.56, compared to a current price of HK$2.50 — trading 55% below its estimated fair value. The current Current Ratio is 2.79, which is 39% below median its 10-year median of 4.60 and 89.8% above the Healthcare Providers & Services industry median of 1.47. EuroEyes International Eye Clinic's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current Current Ratio is 2.79 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.50 is trading 55% below its estimated GF Value™ of HK$5.56.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
Current Ratio: 2.79 (39% below median its 10-year median of 4.60)
GF Value™: HK$5.56 vs. price of HK$2.50 (55% below fair value)
Industry Position: 89.8% above the Healthcare Providers & Services median (#161 of 678)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
83GF Score
Get the complete analysis for HKSE:01846
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
